Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Alx Oncology Holdings (ALXO) recorded Net Equity Issued and Repurchased of $73,000 in Q2 2026, down 89.1% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

On a TTM basis, Alx Oncology Holdings' Net Equity Issued and Repurchased came in at $2.06 million as of Jun 30, 2026, up 155.5% year-over-year; for FY2025, it was $1.69 million, down 94.3% from FY2024.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -65.9% (FY2020 to FY2025).
  • Across earlier years, Net Equity Issued and Repurchased came in at $29.66 million in FY2024, $523,000 in FY2023 (-7.8%), $567,000 in FY2022 (-77.8%) and $2.55 million in FY2021 (-99.3%).
  • The Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased since Q3 2022.
  • On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last four quarters, with growth averaging 88.3%.
  • Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 266.6% in Q4 2025, against a decline of 99.7% in Q4 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 6.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 9.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Alx Oncology Holdings 168.62 Mn 168.62 Mn - 73,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73,000.00
Mar 31, 2026 670,000.00
Dec 31, 2025 1.32 Mn
Mar 31, 2025 372,000.00
Dec 31, 2024 359,000.00
Sep 30, 2024 75,000.00
Jun 30, 2024 26.20 Mn
Mar 31, 2024 3.02 Mn
Dec 31, 2023 185,000.00
Dec 31, 2022 222,000.00
Sep 30, 2022 5,000.00
Jun 30, 2022 155,000.00
Mar 31, 2022 185,000.00
Dec 31, 2021 529,000.00
Sep 30, 2021 543,000.00
Jun 30, 2021 701,000.00
Mar 31, 2021 778,000.00
Dec 31, 2020 195.53 Mn
Sep 30, 2020 68.04 Mn
Jun 30, 2020 -311,000.00
API Access

Alx Oncology Holdings Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALXO&period=max&api_key=YOUR_API_KEY